An episomally maintained MDR1 gene for gene therapy

Human Gene Therapy

Volumn 12, Issue 8, 2001, Pages 945-953

  Lee, C G L ^b,c,d   Vieira, W D ^a   Pastan, I ^a   Gottesman, M M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Johns Hopkins Singapore   (Singapore)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EXTRACHROMOSOMAL DNA; GLYCOPROTEIN P; LIPOSOME; RECOMBINANT DNA;

ARTICLE; BONE MARROW CELL; CANCER; CANCER CHEMOTHERAPY; CELL STRAIN KB; CONTROLLED STUDY; DRUG SELECTIVITY; EPISOME; EPSTEIN BARR VIRUS; FLUORESCENCE; GENE CONSTRUCT; GENE EXPRESSION; GENE REPLICATION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; RETROVIRUS; SAFETY; TRANSGENE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD34; CELL NUCLEUS; CELL SEPARATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, MDR; GENETIC VECTORS; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; LIPOSOMES; MICE; MODELS, GENETIC; P-GLYCOPROTEIN; PLASMIDS; REPLICATION ORIGIN; TIME FACTORS; TRANSFECTION; TRANSGENES; TUMOR CELLS, CULTURED;

DNA VIRUSES; HUMAN HERPESVIRUS 4; MUS MUSCULUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0034913858     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750195908     Document Type: Article

References (53)

1. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
2. In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells
3. Human gene marker/therapy clinical protocols (complete updated listings)
4. Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector
5. Construction and characterization of a selectable multidrug resistance glucocerebrosidase fusion gene
6. Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using bicistronic MDR retrovirus and a new selection strategy
7. Therapeutic gene delivery in human B lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus
8. Expression of the human multidrug resistance and glucocerebrosidase cDNAs from adeno-associated vectors: Efficient promoter activity of AAV sequences and in vivo delivery via liposomes
9. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice
10. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters
11. Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: A pilot trial
12. Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency
13. Recombinant shuttle vectors for the study of mutation in mammalian cells
14. Improved cationic lipid formulations for in vivo gene therapy
15. Genetic analysis of the multidrug transporter
16. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein
17. Functional role for the 170-to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies
18. Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells
19. Human MDR gene transfer in patients with advanced cancer
20. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemo-protection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation
21. Selective extraction of polyma DNA from infected mouse cultures
22. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
23. Characterization of an MDR1 retroviral bicistronic vector for correction of X-linked severe combined immunodeficiency
24. Nonviral gene therapy: The promise of genes as pharmaceutical products
25. Efficient long-term co-expression of a hammerhead ribozyme targeted to the U5 region of HIV-1 LTR by linkage to the multidrug-resistance gene
26. Retroviral transfer of the human MDR1 gene into human T-lymphocytes
27. Delivery systems for the MDR1 gene
28. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
29. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1
30. Epstein-Barr virus based expression vectors
31. Harvey murine sarcoma virus/MDR1 retroviral vectors: Efficient virus production and foreign gene transduction using MDR1 as a selectable marker
32. Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer
33. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells
34. Functional characterization of a glycine 185-to-valine substitution in human P glycoprotein by using a vaccinia-based transient expression system
35. Epstein-Barr virus vectors for gene delivery to B lymphocytes
36. Shuttle vectors for studying mutagenesis in mammalian cells
37. Nonviral approaches to gene therapy
38. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: A new mechanism for selective inhibition of proteolysis
39. Stable episomal maintenance of yeast artificial chromosomes in human cells
40. On the strategy of using non-viral carriers in cancer gene therapy
41. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1
42. Efficient expression of drug-selectable genes in retroviral vectors under control of an internal ribosome entry site
43. Retroviral coexpression of a multidrug resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry disease
44. Coexpression of a multidrug-resistance gene (MDR1) and herpes simplex virus thymidine kinase gene as part of a bicistronic messenger RNA in a retrovirus vector allows selective killing of MDR1-transduced cells
45. Human artificial episomal chromosomes for cloning large DNA fragments in human cells
46. Improved DNA: Liposome complexes for increased systemic delivery and gene expression
47. Systemic gene therapy: Biodistribution and long term expression of a transgene in mice
48. Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism
49. Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene
50. Properties of the earliest clonogenic hemopoietic precursors to appear in the developing murine yolk sac
51. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells
52. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
53. Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic vector